Copertina

Multi‐modal machine learning and gut microbiome pathway analysis for Alzheimer's risk prediction

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Tallat Jabeen, Faezeh Karimi, Ali R. Zomorrodi, Kaveh Khalilpour
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Multi‐modal machine learning for predicting amyloid positivity using on‐ramp driving
di: Sai Santosh Reddy Danda, et al.
Pubblicazione: (2025)

Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
di: Patrick H. Luckett, et al.
Pubblicazione: (2026)

Long‐term Alzheimer's disease mortality prediction in adults aged ≥60 years: A prospective cohort study benchmarking survival machine learning algorithms
di: Xiaoping Huang, et al.
Pubblicazione: (2025)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
di: Jacqueline Chua, et al.
Pubblicazione: (2025)

Multilevel prediction of Alzheimer's disease dementia in the United States: An artificial intelligence analysis
di: Nicolaas P. Pronk, et al.
Pubblicazione: (2026)

BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease
di: Kyle J. Edmunds, et al.
Pubblicazione: (2025)

Dementia ascertainment in India and development of nation‐specific cutoffs: A machine learning and diagnostic analysis
di: Danny Maupin, et al.
Pubblicazione: (2025)

Opportunities to encourage adoption of a biomarker‐enabled care pathway for Alzheimer's in primary care
di: Soo Borson, et al.
Pubblicazione: (2025)

Microstructural alterations in the locus coeruleus‐entorhinal cortex pathway in Alzheimer's disease and frontotemporal dementia
di: Giulia Quattrini, et al.
Pubblicazione: (2024)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
di: Andrée‐Ann Baril, et al.
Pubblicazione: (2024)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
di: Darren M. Lipnicki, et al.
Pubblicazione: (2026)

Corrections to “An explainable machine learning model of cognitive decline derived from speech”
Pubblicazione: (2024)

Mid‐ and late‐life depression increases risk of Alzheimer's disease and related dementias in veterans
di: Lay Kodama, et al.
Pubblicazione: (2026)

Examining the propensity and nature of criminal risk behaviours in frontotemporal dementia syndromes and Alzheimer's disease
di: Fiona Kumfor, et al.
Pubblicazione: (2024)

Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms
di: Sonja M. Kagerer, et al.
Pubblicazione: (2024)

Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease study 2021
di: Fang Wang, et al.
Pubblicazione: (2025)

Machine learning models of Alzheimer's disease spectrum using blood tests
di: Nicola Walter Falasca, et al.
Pubblicazione: (2025)

Advancing dementia identification using machine learning and real‐world sequential health data
di: Cristian Gonzalez‐Prieto, et al.
Pubblicazione: (2026)

Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging
di: Yuxin Li, et al.
Pubblicazione: (2026)

Considerations for disclosing Alzheimer's disease risk and biomarker results in a Pueblo community in Southwest United States
di: Sephira Ryman, et al.
Pubblicazione: (2026)

Family history, perceived risk, and perceived threat of Alzheimer's disease among Latino residents of northern Manhattan
di: Eleanor J. Murphy, et al.
Pubblicazione: (2026)

Omega‐3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer's disease dementia
di: Iolanda Lázaro, et al.
Pubblicazione: (2024)

Brain atrophy and clinical diagnosis independently predict default mode network failure across the Alzheimer's disease continuum
di: Mohammed Alghamdi, et al.
Pubblicazione: (2026)

Digital cognition plus plasma p‐Tau217 and Aβ42/40 powerfully predict Alzheimer's progression
di: Ahmet Begde, et al.
Pubblicazione: (2026)

Increased risk of infusion‐related reactions switching between monoclonal antibodies for Alzheimer's disease: A case series
di: Ganesh Gopalakrishna, et al.
Pubblicazione: (2026)

Correction to “A machine learning approach for potential Super‐Agers identification using neuronal functional connectivity networks”
Pubblicazione: (2024)

Midlife sensory and motor functions improve prediction of blood‐based measures of neurodegeneration and Alzheimer's disease in late middle‐age
di: Adam J. Paulsen, et al.
Pubblicazione: (2024)

Delayed primacy recall performance predicts post mortem Alzheimer's disease pathology from unimpaired ante mortem cognitive baseline
di: Davide Bruno, et al.
Pubblicazione: (2024)

The relative contribution of modifiable and non‐modifiable factors for determining cognition in mid‐life individuals at risk for late‐life Alzheimer's disease
di: Bolin Cao, et al.
Pubblicazione: (2026)

Age‐related macular degeneration severity and risk of Alzheimer's disease in older adults in a prospective, community‐based cohort study
di: Chloe A. Krakauer, et al.
Pubblicazione: (2026)

Machine learning to discover factors predicting volume of white matter hyperintensities: Insights from the UK Biobank
di: Yigizie Yeshaw, et al.
Pubblicazione: (2025)

A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions
di: Ananthan Ambikairajah, et al.
Pubblicazione: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
di: Sunu Mathew, et al.
Pubblicazione: (2025)

Fully automated MRI‐based analysis of the locus coeruleus in aging and Alzheimer's disease dementia using ELSI‐Net
di: Max Dünnwald, et al.
Pubblicazione: (2025)

Technology‐based instrumental activities of daily living in persons with Alzheimer's disease and related disorders
di: Jared F. Benge, et al.
Pubblicazione: (2024)

Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology
di: Nicholas R. Ray, et al.
Pubblicazione: (2024)

Plasma p‐tau217 and APOE genotype: Prodromal Alzheimer's disease staging
di: Ann M. Stowe, et al.
Pubblicazione: (2026)

Smartphone automated motor and speech analysis for early detection of Alzheimer's disease and Parkinson's disease: Validation of TapTalk across 20 different devices
di: Renjie Li, et al.
Pubblicazione: (2024)

Diagnostic utility of plasma p‐tau217 differs by Alzheimer's disease tau‐based subtypes
di: Seyed Hani Hojjati, et al.
Pubblicazione: (2025)

Real‐world use of lecanemab: patient pathway findings from a US multicenter study
di: Michael Rosenbloom, et al.
Pubblicazione: (2026)